The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Endoplex F
Cimicifuga Racemosa, Fucus Vesiculosus, Glycyrrhiza Glabra, Xanthoxylum Fraxineum, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Hypothalamus (Suis), Oophorinum (Suis), Pineal (Suis), Thyroidinum (Suis), Pulsatilla (Vulgaris), Sepia · BLACK COHOSH 3 [hp_X]/mL; FUCUS VESICULOSUS 3 [hp_X]/mL; GLYCYRRHIZA GLABRA 3 [hp_X]/mL; ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; SUS SCROFA CEREBRUM 8 [hp_X]/mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL; SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; SUS SCROFA PINEAL GLAND 8 [hp_X]/mL; THYROID 8 [hp_X]/mL; PULSATILLA VULGARIS WHOLE 12 [hp_X]/mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/mL · Liquid · Oral · BioActive Nutritional, Inc.
NDC 43857-0417-01 · 30 mL in 1 BOTTLE, DROPPER · UNAPPROVED HOMEOPATHIC · View full market →
Medicare Part D
Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Cimicifuga Racemosa, Fucus Vesiculosus, Glycyrrhiza Glabra, Xanthoxylum Fraxineum, Adrenalinum, Cerebrum Suis, Hypophysis Suis, Hypothalamus (Suis), Oophorinum (Suis), Pineal (Suis), Thyroidinum (Suis), Pulsatilla (Vulgaris), Sepia (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BioActive Nutritional, Inc. | BLACK COHOSH 3 [hp_X]/mL; FUCUS VESICULOSUS 3 [hp_X]/mL; GLYCYRRHIZA GLABRA 3 [hp_X]/mL; ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; SUS SCROFA CEREBRUM 8 [hp_X]/mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL; SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; SUS SCROFA PINEAL GLAND 8 [hp_X]/mL; THYROID 8 [hp_X]/mL; PULSATILLA VULGARIS WHOLE 12 [hp_X]/mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/mL | Aug 26, 2026 | Sep 2, 2026 |
| BioActive Nutritional, Inc. | BLACK COHOSH 3 [hp_X]/mL; FUCUS VESICULOSUS 8 [hp_X]/mL; GLYCYRRHIZA GLABRA 3 [hp_X]/mL; ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL; EPINEPHRINE 12 [hp_X]/mL; SUS SCROFA CEREBRUM 12 [hp_X]/mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL; SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; SUS SCROFA PINEAL GLAND 8 [hp_X]/mL; THYROID 8 [hp_X]/mL; PULSATILLA VULGARIS WHOLE 8 [hp_X]/mL; SEPIA OFFICINALIS JUICE 3 [hp_X]/mL | Jul 22, 2026 | Aug 19, 2026 |
| BioActive Nutritional, Inc. | BLACK COHOSH 3 [hp_X]/mL; EPINEPHRINE 8 [hp_X]/mL; FUCUS VESICULOSUS 3 [hp_X]/mL; GLYCYRRHIZA GLABRA 3 [hp_X]/mL; PULSATILLA VULGARIS WHOLE 12 [hp_X]/mL; SEPIA OFFICINALIS JUICE 12 [hp_X]/mL; SUS SCROFA CEREBRUM 8 [hp_X]/mL; SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL; SUS SCROFA OVARY 8 [hp_X]/mL; SUS SCROFA PINEAL GLAND 8 [hp_X]/mL; SUS SCROFA PITUITARY GLAND, POSTERIOR 8 [hp_X]/mL; THYROID 8 [hp_X]/mL; ZANTHOXYLUM AMERICANUM BARK 3 [hp_X]/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Endoplex F — NDC 43857-0417-01," retrieved September 3, 2026, https://drugdashboards.com/drug/43857041701.
Free to cite with attribution — see how the data is put together.